Literature DB >> 19462294

Performance monitoring of substance use disorder interventions in the Veterans Health Administration.

Keith Humphreys1, Alex H S Harris, Daniel R Kivlahan.   

Abstract

BACKGROUND: Measuring and improving the quality of treatment for patients with substance use disorders are enduring challenges.
METHODS: This article describes how the Veterans Affairs health care system is using incentivized performance measures to promote more effective delivery of interventions for nicotine, illegal drug, and alcohol disorders.
RESULTS: The monitoring and incentive system has increased the delivery of evidence-based services, including screening for alcohol use disorders.
CONCLUSIONS: Further work remains to be done to strengthen the connection between process-based measures and longer-term patient outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19462294     DOI: 10.1080/00952990802707042

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  3 in total

1.  Advancing performance measures for use of medications in substance abuse treatment.

Authors:  Cindy Parks Thomas; Deborah W Garnick; Constance M Horgan; Frank McCorry; Amanda Gmyrek; Mady Chalk; David R Gastfriend; Suzanne Gelber Rinaldo; Joann Albright; Victor A Capoccia; Alex H S Harris; Henrick J Harwood; Pamela Greenberg; Tami L Mark; Huong Un; Marla Oros; Mark Stringer; James Thatcher
Journal:  J Subst Abuse Treat       Date:  2010-10-08

2.  Predictors of Mental Health Care Utilization in Veterans With Post-Traumatic Stress Disorder Symptoms and Hazardous Drinking.

Authors:  Emily M Johnson; Kimberly A Barrie; Kyle Possemato; Michael Wade; April Eaker; Paige C Ouimette
Journal:  Mil Med       Date:  2016-10       Impact factor: 1.437

3.  Are Improvements in Measured Performance Driven by Better Treatment or "Denominator Management"?

Authors:  Alex H S Harris; Cheng Chen; Anna D Rubinsky; Katherine J Hoggatt; Matthew Neuman; Megan E Vanneman
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.